PSIP1 and systemic lupus erythematosus: In addition, in animal experiments with lupus-prone mice improved survival rates were demonstrated after weekly infusions of anti-DFS70 antibodies, implicating anti-DFS70 antibodies as a possible therapeutic approach (39).